MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-11-0046453
Akrovis Pharmaceuticals Private Limited
Akrovis Pharmaceuticals Private Limited - trading in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹7.86 Cr
▲ 15% YoY
Net profit · FY 2025
₹39.14 Lakh
Net margin 5%
EBITDA · FY 2025
₹70.29 Lakh
EBITDA margin 8.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹34.61 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
26
Provident fund records
About Akrovis Pharmaceuticals Private Limited
Data last updated:
Akrovis Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 31 August 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC403992.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Krishan Kumar Yadav and Vinod Kumar Ojha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dda Shop No.202 Pocket Bg – 8 Lsc Paschim Vihar, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.86 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹39.14 Lakh (net margin 5%) and EBITDA of ₹70.29 Lakh (EBITDA margin 8.9%).
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹34.61 Lakh on record.
Akrovis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0046453).
Company details
CIN U51909DL2022PTC403992
Registration Number 403992
Incorporation Date 31 August 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0046453
Recognitions & Rankings of Akrovis Pharmaceuticals
Contact details
Akrovis Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressDda Shop No.202 Pocket Bg – 8 Lsc Paschim Vihar, Delhi, India – 110063
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Akrovis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Akrovis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Akrovis Pharmaceuticals Private Limited, buy the company report.
Financials of Akrovis Pharmaceuticals Private Limited
FY 2025 filings availableAkrovis Pharmaceuticals Private Limited reported revenue of ₹7.86 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹7.86 Cr ▲ 15%
Net profit · FY 2025
₹39.14 Lakh margin 5%
EBITDA · FY 2025
₹70.29 Lakh margin 8.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
EBITDA CAGR growth
1 year
▲ 23%
Revenue rose 15% in the latest year. EBITDA rose 23% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹70.29 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹39.14 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.9% | ||
| Net Profit Margin | 5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Akrovis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Akrovis Pharmaceuticals Private Limited
Akrovis Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishan Kumar Yadav | Director | 31 Aug 2022 | 4 Years 2 Months | Current |
| Vinod Kumar Ojha | Director | 31 Aug 2022 | 4 Years 2 Months | Current |
| Varun Gupta | Director | 31 Aug 2022 | 4 Years 2 Months | Current |
| Yogesh Yadav | Director | 07 Nov 2022 | 3 Years 11 Months | Current |
| Sandeep Kumar Singh | Director | 07 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Akrovis Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akrovis Pharmaceuticals Private Limitedthis company | ₹7.86 Cr (FY 2025) | ₹39.14 Lakh | 5% | 15.0% | Delhi, India | |
| DNS Drugs & Pharmaceuticals Private Limited | ₹7.79 Cr (FY 2024) | 15.0% | Dombivli, Maharashtra, India | |||
| Atrey Pharmaceuticals Private Limited | ₹7.76 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Lexmark Pharmaceuticals Private Limited | ₹7.76 Cr (FY 2025) | -8.0% | Unjha, Gujarat, India |
To see the full peer comparison of Akrovis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹34.61 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jun 2024 | 100958366 | Hdfc Bank Limited | ₹8.45 Lakh | Open | |
| 29 Jan 2024 | 100892544 | Hdfc Bank Limited | ₹9.07 Lakh | Open | |
| 17 Nov 2023 | 100845809 | Hdfc Bank Limited | ₹9.09 Lakh | Open | |
| 29 Mar 2023 | 100722578 | Hdfc Bank Limited | ₹8 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Akrovis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akrovis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Akrovis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Akrovis Pharmaceuticals Private Limited has 7 board changes on record since 2022: 5 appointments and 2 cessations. The latest: Sandeep Kumar Singh ceased to be Additional Director on 29 Dec 2023.
AGM
Akrovis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Akrovis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.45 Lakh with Charge ID 100958366 was registered on 25 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.07 Lakh with Charge ID 100892544 was registered on 29 Jan 2024.
Ceased
Sandeep Kumar Singh ceased to be Additional Director.
Ceased
Yogesh Yadav ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.09 Lakh with Charge ID 100845809 was registered on 17 Nov 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Lakh with Charge ID 100722578 was registered on 29 Mar 2023.
Appointed
Sandeep Kumar Singh was appointed as Director.
Appointed
Yogesh Yadav was appointed as Director.
Appointed
Krishan Kumar Yadav was appointed as Director.
Appointed
Varun Gupta was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Akrovis Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 31 August 2022 (4+ years old) and is registered under CIN U51909DL2022PTC403992.
Akrovis Pharmaceuticals has 5 current directors:
- Krishan Kumar Yadav - Director
- Vinod Kumar Ojha - Director
- Varun Gupta - Director
- Yogesh Yadav - Director
- Sandeep Kumar Singh - Director
The latest financial statements of Akrovis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Akrovis Pharmaceuticals is U51909DL2022PTC403992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akrovis Pharmaceuticals was incorporated on 31 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Akrovis Pharmaceuticals by revenue are DNS Drugs & Pharmaceuticals Private Limited, Atrey Pharmaceuticals Private Limited, Lexmark Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sandeep Kumar Singh ceased to be Additional Director on 29 Dec 2023. Yogesh Yadav ceased to be Additional Director on 29 Dec 2023. Sandeep Kumar Singh was appointed as Director on 07 Nov 2022. Akrovis Pharmaceuticals has 7 board changes on record in total.
Yes, Akrovis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0046453).
The registered office of Akrovis Pharmaceuticals is at Dda Shop No.202 Pocket Bg – 8 Lsc Paschim Vihar, Delhi, India – 110063.
Akrovis Pharmaceuticals operates in the trading industry, in the specialty segment.
Akrovis Pharmaceuticals has open charges of ₹34.61 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages